{"name":"Ginkgo Bioworks","slug":"ginkgo","ticker":"DNA","exchange":"NYSE","domain":"ginkgobioworks.com","description":"Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed \"Organism Company\" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.","hq":"Boston, MA","founded":0,"employees":"485","ceo":"Jason Kelly","sector":"Synthetic Biology / Platform","stockPrice":6.91,"stockChange":0.09,"stockChangePercent":1.32,"marketCap":"$428M","metrics":{"revenue":170155000,"revenueGrowth":-23.8,"grossMargin":72.4,"rdSpend":243773000,"netIncome":-312763000,"cash":422620000,"dividendYield":0,"peRatio":-1.9,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"GB-102 patent cliff ($0.0B at risk)","drug":"GB-102","type":"patent_expiry","sentiment":"negative"},{"date":"2032-06-01","label":"GB-103 patent cliff ($0.0B at risk)","drug":"GB-103","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Ginkgo Bioworks reported its fourth quarter and full year 2023 financial results, with revenue of $143.4 million and a net loss of $1.4 billion.","drugName":"","sentiment":"neutral"},{"date":"2023-12-14","type":"deal","headline":"Ginkgo Bioworks and Merck Announce Collaboration to Develop Novel Therapeutics","summary":"Ginkgo Bioworks and Merck announced a collaboration to develop novel therapeutics using Ginkgo's platform technology.","drugName":"","sentiment":"positive"},{"date":"2023-09-12","type":"regulatory","headline":"FDA Grants Ginkgo Bioworks Orphan Drug Designation for GB-102","summary":"The FDA granted orphan drug designation to Ginkgo Bioworks' GB-102 for the treatment of glioblastoma.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-04-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-01","type":"pipeline","source":"simplywall.st","summary":"A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture - simplywall.st","headline":"A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxNVUUweUpoVVhkWGw2S3FqVjFRN2JrTVFBTlcyMXNob2FKVGI1bmtONG1TR1pPSVhOSXk2V3FUS2RTblE0YXJQVFNyREhrNTg0MWhjQ00yRGNGRE1vSmxHbndrRnZyejdBNTk1TU9XTDJrcG00VTJFdl82SzY3UTVtWDkxaGsyY19ULW9rbC1UZjZtWVRuOHNEWlhmbXJiWGVrbGNFVGxWdEc2Y1d0RWpKakRtcGVabEtkUElEbnRTTldtQ0lwSDZQSXdyTDBkaW9wWXZfdkVkYzYwQVZCVTNkQmNLdjRLdDJsS09SdTlYMGFGWkFWNHdhRWNfeXQ4WjUwT08yMjJn?oc=5","date":"2026-02-27","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Xenon (XENE) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Xenon (XENE)","sentiment":"neutral"},{"date":"2026-02-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-26","type":"pipeline","source":"simplywall.st","summary":"Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0% - simplywall.st","headline":"Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0%","sentiment":"neutral"},{"date":"2025-12-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNaS1kcVFDNmhTanFrZXdvdTdmUDFSU2FYTHAyQnpNX1lTaUtTQ3ZWeHlPeVoySXhsNkplbUpKdzdzc0ZkMEdmeklYRTRYeFlEREpNMm0wTEhBUVI5OEdZRkRkZ1hiRnJqQ2JYWlNPTnlESWRuUDQwNjRES0F2WHlVQldidlF6endkZU4zcUNrRGF1MWpsc2h3NUZDRFBRcDMzaTFB?oc=5","date":"2025-12-03","type":"trial","source":"genomeweb.com","summary":"Illumina, Other Genomics Firms Ramp Up Data Offerings for Pharma, With Eyes on AI - genomeweb.com","headline":"Illumina, Other Genomics Firms Ramp Up Data Offerings for Pharma, With Eyes on AI","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-19","type":"pipeline","source":"simplywall.st","summary":"Could Ginkgo Bioworks (DNA) Leverage Academic Ties to Reinforce Its Microbiome Research Edge? - simplywall.st","headline":"Could Ginkgo Bioworks (DNA) Leverage Academic Ties to Reinforce Its Microbiome Research Edge?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-17","type":"pipeline","source":"simplywall.st","summary":"Why Investors Shouldn't Be Surprised By Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) 39% Share Price Plunge - simplywall.st","headline":"Why Investors Shouldn't Be Surprised By Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) 39% Share Price Plunge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNdVVJT2ZReUVWYUwxbmpYcEh6OWdXeHFtbW9tZGUwUGVPSllTcHVFdElFR05KNHNadS1GNDFidUZCbENoRW44ZGU5SFFjdU9GZEJtU2VUcXlMYUNTMWJ2VGJWeGRtVzVQTEYwSWtPU1dFdzFpSnBGUkh2Y2JzRWw3c3FNcXY5Mi0xWnFJWGd6TU1PcUlZcThoT1l0NzE0VUFZZmR4S1gzcTFXNXlJYnBlclhpLUJORkkxbUl4aV93SEZTNi1ITUF5NDBrTDhOU0RoR2N1NERLN2IxbGU3UjBqQWtqVTZZLU5EcnNHeXFiVnJKeTVZQVV0YmQ3YV9NdXVZZEFHVW1Ncy1zSktSd0o4?oc=5","date":"2025-04-10","type":"deal","source":"PR Newswire","summary":"Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain - PR Newswire","headline":"Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPVnFGWnVSM2taMWsxLUhTTTY1bFVfeDR6U1ZwZjBVM2dnTlp6VTBsTDNlTXhBMDhJaDRvLXRYdVQ0YVU4cHFsdGw5UGU5aGlKcnlycUt6Wlc5blF3MDFJa0MwLU5FZU9iLVpjNjJFWVYwMUJVcloxNmxsd0RJUmh4cm9UVXY0ZEhiaWNXTW50NFVwY1BMUV91UEM5MlRITFdDem9QTGVNWUlCNUlkWGFBMTViQ1JvUDBxT0xUN2E3dTZjS0NFX1V5aHluTmZpck41RUFLVVVUVQ?oc=5","date":"2024-11-12","type":"deal","source":"PR Newswire","summary":"Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - PR Newswire","headline":"Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNUF81eTZXcmZObnhBU1U3SEhfRUM1YnI5WGpXV1BUSnkwV3h2VVhnSFZ6V2hYM05Lbk8yb2E1OVFkakhlQVFWX1ZLZ293S3VrN1NVM2k0ZGk2aDM4YUVhOFFFLWtsMUNXMnpFUVItWWhQZmRvUUtTOGREQjJxMVdPd3h1d01XdWtyWmNsUXBkbHdLMkFmeEp5MVFPcFpTdVZ1Z2VNYTNraXBHTnNyTmJjUC1KTWFIc21tZzRIQUtSeXkwUjAwN20xemJFVHYyT3lVSFluZmZhR3k?oc=5","date":"2024-04-10","type":"pipeline","source":"PR Newswire","summary":"Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain - PR Newswire","headline":"Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNbEVIbW53ekhRR19IUkdTVnFLZWV6RTBZdWd3VmV5Uy1yQ2V3a1FORnUtanlMSjdySmhGbTlvV2tCNXFpcFpDWjN0d3ZaeV9PNHNSS1Azc2YzN0kyNE9xUTg1bm55QUFIbjYxLUF3TzFCeGJYYjgxdU8yS0dYWGZlMTdsbE1fNm9Lc0dMNHdXOA?oc=5","date":"2023-12-07","type":"pipeline","source":"Pharmaceutical Technology","summary":"Synplogen and Ginkgo Bioworks sign MoU for DNA manufacturing - Pharmaceutical Technology","headline":"Synplogen and Ginkgo Bioworks sign MoU for DNA manufacturing","sentiment":"neutral"}],"patents":[{"drugName":"GB-102","drugSlug":"gb-102","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":0},{"drugName":"GB-103","drugSlug":"gb-103","patentNumber":"","type":"Patent Cliff","expiryDate":"2032-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Synlogic","Amyris","Editas Medicine"],"therapeuticFocus":["Oncology","Rare Diseases"],"financials":{"source":"sec_edgar","revenue":170155000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":170155000,"period":"2025-12-31"},{"value":227043000,"period":"2024-12-31"},{"value":227043000,"period":"2024-12-31"},{"value":251455000,"period":"2023-12-31"},{"value":251455000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":243773000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-312763000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":1119696000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":6.91,"previousClose":6.82,"fiftyTwoWeekHigh":17.58,"fiftyTwoWeekLow":5.37,"fiftyTwoWeekRange":"5.37 - 17.58","fiftyDayAverage":7.91,"twoHundredDayAverage":10.29,"beta":1.57,"enterpriseValue":414238784,"forwardPE":-1.9,"priceToBook":0.79,"priceToSales":2.51,"enterpriseToRevenue":2.43,"enterpriseToEbitda":-1.55,"pegRatio":0,"ebitda":-267822000,"ebitdaMargin":-157.4,"freeCashflow":-72883000,"operatingCashflow":-171059008,"totalDebt":439884992,"debtToEquity":86.5,"currentRatio":4.92,"returnOnAssets":-15.4,"returnOnEquity":-51.1,"analystRating":"","recommendationKey":"none","numberOfAnalysts":3,"targetMeanPrice":8.67,"targetHighPrice":12,"targetLowPrice":5,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":3.3,"institutionHeldPercent":73.1,"sharesOutstanding":49941878,"floatShares":41656053,"sharesShort":8004118,"shortRatio":6.61,"shortPercentOfFloat":12.9,"epsTrailing":-5.64,"epsForward":-3.63,"revenuePerShare":3.07,"bookValue":8.74,"officers":[{"age":43,"name":"Dr. Jason  Kelly Ph.D.","title":"Co-Founder, Co-COO, CEO & Director"},{"age":43,"name":"Dr. Reshma P. Shetty","title":"Co-Founder, President, COO Director"},{"age":null,"name":"Mr. Thomas  Knight Jr.","title":"Founder"},{"age":null,"name":"Mr. Austin  Che Ph.D.","title":"Co-Founder & Head of Strategy"},{"age":null,"name":"Mr. Bartholomew  Canton Ph.D.","title":"Co-Founder & CTO"},{"age":null,"name":"Mr. Steven P. Coen CPA","title":"Chief Financial Officer"},{"age":null,"name":"Ms. Jennifer  Wipf","title":"Co-Chief Operating Officer"},{"age":null,"name":"Ms. Karen  Tepichin","title":"General Counsel & Secretary"}],"industry":"Biotechnology","irWebsite":"","website":"https://www.ginkgo.bio","phone":"877 422 5362"}}